ABSTRACT
Tumor-associated macrophages (TAM) are immunosuppressive cells that can massively accumulate in the tumor microenvironment. In patients with ovarian cancer, their density is correlated with poor prognosis. Targeting mediators that control the generation or the differentiation of immunoregulatory macrophages represents a therapeutic challenge to overcome tumor-associated immunosuppression. The ectonucleotidase CD39 hydrolyzes ATP into extracellular adenosine that exhibits potent immunosuppressive properties when signaling through the A2A adenosine receptor. We report here that CD14+ CD163+ TAM isolated from ovarian cancer patients and macrophages generated in vitro with M-CSF, express high levels of the membrane ectonucleotidase CD39 compared to classically activated macrophages. The CD39 inhibitor POM-1 and adenosine deaminase (ADA) diminished some of the immunosuppressive functions of CD14high CD163high CD39high macrophages, such as IL-10 secretion. We identified the cytokine IL-27, secreted by tumor-infiltrating neutrophils, located close to infiltrating CD163+ macrophages, as a major rheostat of CD39 expression and consequently, on the acquisition of immunoregulatory properties by macrophages. Accordingly, the depletion of IL-27 downregulated CD39 and PD-L1 expression as well as IL-10 secretion by M-CSF-macrophages. Collectively, these data suggest that CD39, drived by IL-27 and CD115 ligands in ovarian cancer, maintains the immunosuppressive phenotype of TAM. This work brings new information on the acquisition of immunosuppressive properties by tumor-infiltrating macrophages.
Disclosure of potential conflicts of interest
No potential conflicts of interest were disclosed.
Acknowledgments
The authors thank Dimitri Breard and David Macherel for HPLC experiments. The authors also thank members of the cellular and molecular facility (PACeM) of the University of Angers and members of the Cellular and Tissular Imaging core facility (MicroPICell) of the University of Nantes. The authors are grateful to Simon Blanchard, Isabelle Fremaux and Laurence Preisser for expert technical assistance.
Author contributions
Conceived and designed the experiments: SMDA, PJ, MG, YD, JT. Performed the experiments: SMDA, GK, CR, LB, LP. Analyzed the data: SMDA, GK, CR, LB, DH, AC, PJ, MG, YD, JT. Contributed reagents/materials/analysis tools: VC, NI, PD, AC. Wrote the paper: SMDA, PJ, MG, YD, JT.
Funding
This work was supported by institutional grants from INSERM and the University of Angers, and by a grant from the regional council Pays de la Loire (IMBIO-DC program) a grant from the Ligue contre le Cancer (Comité Départemental du Maine-et-Loire), and a grant from the Institut Recherche en Santé Respiratoire des Pays de la Loire. SMDA received a financial support from the regional council Pays de la Loire (IMBIO-DC program).